Structure Therapeutics (GPCR) PT Lowered to $113 at Citizens Ahead of Readouts
Tweet Send to a Friend
Citizens analyst Jonathan Wolleben lowered the price target on Structure Therapeutics (NASDAQ: GPCR) to $113.00 (from $120.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
